Pauline Kenny - Dec 16, 2022 Form 4 Insider Report for KINETA, INC./DE (KA)

Role
General Counsel
Signature
/s/ Pauline Kenny, as Attorney-in-Fact
Stock symbol
KA
Transactions as of
Dec 16, 2022
Transactions value $
$0
Form type
4
Date filed
12/20/2022, 07:58 PM
Next filing
Mar 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KA Common Stock Award +10.6K 10.6K Dec 16, 2022 Direct F1
transaction KA Common Stock Award +5.04K +47.41% 15.7K Dec 16, 2022 Direct F2, F3
transaction KA Common Stock Award +3.44K +21.94% 19.1K Dec 16, 2022 Direct F4, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KA Stock Option (Right to Buy) Award +619 619 Dec 16, 2022 Common Stock 619 $12.11 Direct F6, F7
transaction KA Stock Option (Right to Buy) Award +5.16K 5.16K Dec 16, 2022 Common Stock 5.16K $23.11 Direct F6, F8
transaction KA Stock Option (Right to Buy) Award +11K 11K Dec 16, 2022 Common Stock 11K $27.03 Direct F9, F10
transaction KA Stock Option (Right to Buy) Award +5.23K 5.23K Dec 16, 2022 Common Stock 5.23K $23.25 Direct F6, F11
transaction KA Stock Option (Right to Buy) Award +3.44K 3.44K Dec 16, 2022 Common Stock 3.44K $26.16 Direct F12, F13
transaction KA Stock Option (Right to Buy) Award +20K 20K Dec 16, 2022 Common Stock 20K $23.25 Direct F6, F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Received in connection with the Issuer's merger (the "Merger") with Kineta, Inc. ("Legacy Kineta") in accordance with the terms of the Agreement and Plan of Merger dated as of June 5, 2022, as amended on December 5, 2022 (the "Merger Agreement"), by and among the Issuer (f/k/a Yumanity Therapeutics, Inc.), Yacht Merger Sub, Inc. and Legacy Kineta. Pursuant to the terms of the Merger Agreement, each outstanding share of Legacy Kineta common stock was entitled to receive 0.0688 shares of Common Stock. The Merger closed on December 16, 2022.
F2 Represents shares of Common Stock underlying time-based restricted stock unit awards ("RSUs"). The RSUs will vest in full on June 14, 2023, subject to the continuing employment of the Reporting Person on such vesting date.
F3 Received in connection with the Merger in exchange for 73,291 shares of common stock underlying Legacy Kineta RSUs.
F4 Represents shares of Common Stock underlying a time-based RSU. The RSU will vest in full on March 16, 2023, subject to the continuing employment of the Reporting Person on such vesting date.
F5 Received in connection with the Merger in exchange for 50,000 shares of common stock underlying a Legacy Kineta RSU.
F6 The stock option is fully vested and exercisable.
F7 Received in connection with the Merger in exchange for options to acquire 9,000 shares of Legacy Kineta common stock for $0.8333 per share.
F8 Received in connection with the Merger in exchange for options to acquire 75,000 shares of Legacy Kineta common stock for $1.59 per share.
F9 The stock option vested as to 1/3 of the total number of shares on May 31, 2022, and an additional 1/3 of the total number of shares will vest on each yearly anniversary thereafter, until such time as the stock option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
F10 Received in connection with the Merger in exchange for options to acquire 160,000 shares of Legacy Kineta common stock for $1.86 per share.
F11 Received in connection with the Merger in exchange for options to acquire 76,000 shares of Legacy Kineta common stock for $1.60 per share.
F12 The stock option vested as to 1/3 of the total number of shares on May 27, 2021, an additional 1/3 of the total number of shares vested on May 27, 2022, and the remaining 1/3 of the total number of shares will vest on May 27, 2023, subject to the continuing employment of the Reporting Person on each vesting date.
F13 Received in connection with the Merger in exchange for options to acquire 50,000 shares of Legacy Kineta common stock for $1.80 per share.
F14 Received in connection with the Merger in exchange for options to acquire 290,000 shares of Legacy Kineta common stock for $1.60 per share.